Cameron Pitt
Oprichter bij Quanta Therapeutics, Inc.
Profiel
Cameron Pitt is the founder of Quanta Therapeutics, Inc. founded in 2018, where he holds the title of Director & Chief Business Officer.
In 2018, he also started working at Sofinnova Investments, Inc. as a Principal until 2020.
Dr. Pitt has an undergraduate degree from Stanford University and a doctorate from the University of California.
Actieve functies van Cameron Pitt
| Bedrijven | Functie | Begin |
|---|---|---|
Quanta Therapeutics, Inc.
 Quanta Therapeutics, Inc. BiotechnologyHealth Technology Quanta Therapeutics, Inc. develops biotechnologies. The American company was founded in 2018 by Cameron Pitt, Frank McCormick. Perry D. Nisen has been the CEO of the company since 2021. | Oprichter | 01-01-2018 |
Eerdere bekende functies van Cameron Pitt
| Bedrijven | Functie | Einde |
|---|---|---|
Sofinnova Investments, Inc.
 Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment Inc (Sofinnova Investment) is a venture capital firm founded in 1976 by Jacques F. vallle & Joel F. Martin. The firm is headquartered in Menlo Park, California. | Private Equity Analist | 30-04-2020 |
Opleiding van Cameron Pitt
| University of California | Doctorate Degree |
| Stanford University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Sofinnova Investments, Inc.
Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment Inc (Sofinnova Investment) is a venture capital firm founded in 1976 by Jacques F. vallle & Joel F. Martin. The firm is headquartered in Menlo Park, California. | Finance |
Quanta Therapeutics, Inc.
Quanta Therapeutics, Inc. BiotechnologyHealth Technology Quanta Therapeutics, Inc. develops biotechnologies. The American company was founded in 2018 by Cameron Pitt, Frank McCormick. Perry D. Nisen has been the CEO of the company since 2021. | Health Technology |
